Oregon
Oregon
Providence is pleased that union-represented RNs at all eight Oregon hospitals voted to approve new contracts and end their strikes
Providence Oregon is pleased that union-represented RNs at all eight Oregon hospitals voted to approve new contracts and end their strikes.
Providence announces tentative agreements with nurses at all eight Providence hospitals in Oregon
Providence’s Oregon bargaining teams have reached tentative agreements with nurses at all eight Providence hospitals in Oregon.
From life-saving surgery to back on the slopes: A photographer’s story
Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.
Providence Medical Group Announces Tentative Agreement with Hospitalists, Palliative Care Physicians at Providence St. Vincent
Feb. 5, 2025 News Release: Providence Medical Group Announces Tentative Agreement with Hospitalists, Palliative Care Physicians at Providence St. Vincent
Robotic versus open surgery for early cervical cancer
This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.
Joint statement on mediation between Providence and Oregon Nurses Association
Jan. 29, 2025 News Release: Joint statement on mediation between Providence and Oregon Nurses Association
Providence reaches out to begin scheduling mediation
Jan. 11, 2025 News Release: With record numbers of caregivers returning to work, our ministries are now in a position to discuss resuming mediated negotiation sessions.
Top 5 things to know about getting care during ONA strike
Here’s what you need to know about getting care at Providence hospitals and clinic during the Oregon Nurses Association strikes that start Friday, January 10.
Protecting your access to health care is our priority
Jan. 8, 2025 News Release: We have negotiated in good faith to reach agreements with Oregon Nurses Association (ONA), but these strikes will compromise access to care
Providence warns union strike creates "significant risk" for health care in Oregon
Jan. 7, 2025 News Release: Providence informs state leaders the open-ended strike planned by leaders of the Oregon Nurses Association puts health care access at “significant risk” in the state.
Providence is given notice by ONA to strike
Dec. 30, 2024 News Release: Providence is given notice by ONA to strike at multiple Oregon ministries, including our eight acute hospitals
A year to remember: Advancements, recognition and transitions
Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
CAR T cell-therapy, hope and healing: Dean’s story
Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.
Two clinical trials for solid tumor cancers take different approaches to stop growth
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
New studies test immunotherapy to boost breast cancer treatment and prevent return
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Attend a free virtual symposium on melanoma, Oct. 25
Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.
